Base de données de recherche subventionnée canadienne sur la COVID-19

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 331 through 340 of 882 results (Download Results)

Show results per page

A double blind randomized trial of low-dose naltrexone for post-covid fatigue syndrome

Nacul, Luis | B.C. Women's Hospital | Operating Grant | $742,331

CIHR British Columbia 2021

Long COVID and Episodic Disability: Advancing the Conceptualization, Measurement and Knowledge of Episodic Disability with people living with Long COVID

O'Brien, Kelly K | University of Toronto | Operating Grant | $204,205

CIHR Ontario 2021

COVID-19 Variant Supplement – SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.

Wilson, Joyce A | University of Saskatchewan | Operating Grant | $50,000

CIHR Saskatchewan 2021

COVID-19 Variant Network – Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID‑19 treatment

Lemieux, Joanne M | University of Alberta | Operating Grant | $100,000

CIHR Alberta 2021

COVID-19 Variant Supplement – Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity

Leduc, Richard | Université de Sherbrooke | Operating Grant | $50,000

CIHR Quebec 2021

Post-Acute Complications of COVID-19: An International Cohort Study (PACS) Note that in a previous iteration, this proposal was titled PACMAN as indicated in some of the Letters of Support

Leong, Darryl | McMaster University | Operating Grant | $495,684

CIHR Ontario 2021

Development of a rapid and simple test to detect the COVID‑19 variants that can be used in remote areas and developing countries.

Tremblay, Jacques P | Université Laval | Operating Grant | $199,125

CIHR Quebec 2021

A low-cost, portable, and decentralized microfluidic device for detecting SARS-CoV-2 neutralizing antibodies

Little, Dustin J | Ryerson University | Operating Grant | $235,800

CIHR Ontario 2020

Reducing COVID‑19 Vaccine Hesitancy in Canadian Immigrants

Gold, Ian J | McGill University | Operating Grant | $335,734

CIHR Quebec 2021

Opioid Use Disorder Care during COVID‑19 Disruptions

McLane, Patrick | University of Alberta | Operating Grant | $199,806

CIHR Alberta 2020

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

A double blind randomized trial of low-dose naltrexone for post-covid fatigue syndrome

Long COVID and Episodic Disability: Advancing the Conceptualization, Measurement and Knowledge of Episodic Disability with people living with Long COVID

COVID-19 Variant Supplement – SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.

COVID-19 Variant Network – Optimizing polar, small inhibitors of a viral cysteine protease to identify a lead for an oral COVID‑19 treatment

COVID-19 Variant Supplement – Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity

Post-Acute Complications of COVID-19: An International Cohort Study (PACS) Note that in a previous iteration, this proposal was titled PACMAN as indicated in some of the Letters of Support

Development of a rapid and simple test to detect the COVID‑19 variants that can be used in remote areas and developing countries.

A low-cost, portable, and decentralized microfluidic device for detecting SARS-CoV-2 neutralizing antibodies

Reducing COVID‑19 Vaccine Hesitancy in Canadian Immigrants

Opioid Use Disorder Care during COVID‑19 Disruptions